ALGS vs RIVN · rev $3.6M vs rev $5.39B
Aligos Therapeutics Inc (ALGS) versus Rivian Automotive Inc (RIVN) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by RJ Scaringe.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported RIVN revenue for 2025-12-31 was $5.39B. Net income was -$3.65B. Revenue was up 8.4% from 2024-12-31 to 2025-12-31. RIVN currently screens at market cap $21.81B.
ALGS currently screens at market cap $44.1M. RIVN currently screens at market cap $21.81B.
Not investment advice. Open the ALGS and RIVN stock pages for the full models.
Not investment advice.